Department of Thoracic Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Eur J Cardiothorac Surg. 2012 Jan;41(1):31-4; discussion 34-5. doi: 10.1016/j.ejcts.2011.04.003.
Meaningful exposure to oesophageal cancer surgery during general thoracic surgical training is restricted to few centres in the United Kingdom. Our Regional Tertiary Unit remains a rare 'large-volume' oesophagectomy centre. We aimed to determine the proportion of patients operated by trainees and their perioperative outcomes.
From January 2004 to September 2009, 323 patients (229 male and 94 female, median age of 69 (range 40-92) years) underwent oesophagectomy for carcinoma in our Thoracic Surgical Unit. Data were complete and obtained from a prospective departmental database. The preoperative characteristics, operative data and postoperative results were compared between the 120 patients (37%) operated by a trainee (group T) and the remainder 203 patients operated by a consultant (group C).
The overall incidence of mortality, anastomotic leak and chylothorax were 6.5%, 5.3% and 2.2%, respectively. There were no differences in terms of age, gender, tumour location, tumour staging, preoperative spirometry or use of neoadjuvant chemotherapy between the two groups. There was no significant difference between the consultant group and the trainee group in the following key outcome measures: postoperative mortality (8% vs 4%), incidence of respiratory complications (30% vs 25%), hospital stay (14 days vs 13 days) and number of lymph nodes excised (median of 16 vs 14).
Training in oesophageal cancer surgery can be provided in a large-volume thoracic surgical unit. It does not seem to compromise outcomes or use of resources.
在普通胸外科培训中,对食管癌手术的有意义的接触仅限于英国的少数几个中心。我们的区域三级单位仍然是一个罕见的“大容量”食管癌手术中心。我们旨在确定由受训者进行手术的患者比例及其围手术期结果。
从 2004 年 1 月至 2009 年 9 月,我们的胸外科病房共有 323 名(229 名男性和 94 名女性,中位年龄为 69 岁(范围 40-92 岁))接受了食管癌切除术。数据完整,并从一个前瞻性的部门数据库中获得。将受训者(T 组)进行的 120 例患者(37%)与其余由顾问(C 组)进行的 203 例患者的术前特征,手术数据和术后结果进行比较。
总死亡率,吻合口漏和乳糜胸的发生率分别为 6.5%,5.3%和 2.2%。两组在年龄,性别,肿瘤位置,肿瘤分期,术前肺功能或新辅助化疗的使用方面没有差异。顾问组和受训者组之间在以下关键结果指标方面没有显着差异:术后死亡率(8%对 4%),呼吸并发症发生率(30%对 25%),住院时间(14 天对 13 天)和切除的淋巴结数量(中位数为 16 对 14)。
在大容量胸外科单位中可以进行食管癌手术培训。它似乎不会影响结果或资源的使用。